This live educational activity is designed to provide healthcare professionals with evidence-based education in regenerative medicine, including the clinical application of stromal vascular fraction (SVF), exosomes, peptides, and hormone optimization. Through a combination of didactic sessions, panel discussions, and case-based learning, participants will examine mechanisms of action, patient selection, safety considerations, and current regulatory frameworks. The program is intended to enhance clinician competence and support the integration of compliant, scientifically grounded regenerative therapies into clinical practice.

Target Audience

This activity is designed for an audience of physicians, physician assistants, nurse practitioners and nurses.

Learning Objectives

Apply regenerative medicine principles in clinical practice
Evaluate emerging biologics including peptides, exosomes, and PRP
Integrate hormone optimization strategies safely and effectively
Assess patient selection and treatment protocols
Implement procedural techniques to improve patient outcomes

Commercial Support

This activity is supported by an independent medical education grant of in-kind support from Next MD Link and Bella Vita Clinic.

Course summary

Available credit:

16.75 AANP
19.25 AAPA Category 1 CME
19.25 AMA PRA Category 1 Credit™
19.25 ANCC
19.25 Attendance

Course opens:

04/19/2026

Course expires:

12/31/2026

Cost:

$0.00

Rating:

April 17, 2026 - April 19, 2026 Manhattan Beach, CA

United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)